Literature DB >> 20335350

Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse.

Antonio Abbate1, Benjamin W Van Tassell, Ignacio M Seropian, Stefano Toldo, Roshanak Robati, Amit Varma, Fadi N Salloum, Lisa Smithson, Charles A Dinarello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335350     DOI： 10.1093/eurjhf/hfq017

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  52 in total

Review 1.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

2.  Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure.

Authors:  Qiang Liu; Tao Wang; Huapeng Yu; Bin Liu; Ruyi Jia
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 3.  Sensing damage by the NLRP3 inflammasome.

Authors:  Jaklien C Leemans; Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

4.  Role of Interleukin-1 in Radiation-Induced Cardiomyopathy.

Authors:  Eleonora Mezzaroma; Ross B Mikkelsen; Stefano Toldo; Adolfo G Mauro; Khushboo Sharma; Carlo Marchetti; Asim Alam; Benjamin W Van Tassell; David A Gewirtz; Antonio Abbate
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

Review 5.  Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue?

Authors:  Emily L Ongstad; Robert G Gourdie
Journal:  Semin Cell Dev Biol       Date:  2016-05-24       Impact factor: 7.727

6.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

7.  Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.

Authors:  Carlo Marchetti; Stefano Toldo; Jeremy Chojnacki; Eleonora Mezzaroma; Kai Liu; Fadi N Salloum; Andrea Nordio; Salvatore Carbone; Adolfo Gabriele Mauro; Anindita Das; Ankit A Zalavadia; Matthew S Halquist; Massimo Federici; Benjamin W Van Tassell; Shijun Zhang; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2015-07       Impact factor: 3.105

Review 8.  Targeting interleukin-1 in heart failure and inflammatory heart disease.

Authors:  Benjamin W Van Tassell; Juan M Valle Raleigh; Antonio Abbate
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 9.  The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction.

Authors:  Samantha D Francis Stuart; Nicole M De Jesus; Merry L Lindsey; Crystal M Ripplinger
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

10.  Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction.

Authors:  Han Chen; Jing Wang; Mei-Xiang Xiang; Yan Lin; Aina He; Chun-Na Jin; Jian Guan; Galina K Sukhova; Peter Libby; Jian-An Wang; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2013-06-14       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.